|
|
Volumn 28, Issue 2, 2004, Pages 194-205
|
|
The subsidy of pharmaceuticals in Australia: processes and challenges.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADVISORY COMMITTEE;
ARTICLE;
AUSTRALIA;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DEVELOPED COUNTRY;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
HEALTH CARE DELIVERY;
HEALTH INSURANCE;
HUMAN;
INTERNATIONAL COOPERATION;
LEGAL ASPECT;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
PRESCRIPTION;
PUBLICATION;
ADVISORY COMMITTEES;
AUSTRALIA;
CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
DECISION MAKING, ORGANIZATIONAL;
DEVELOPED COUNTRIES;
DRUG APPROVAL;
DRUG COSTS;
DRUG INDUSTRY;
FINANCING, GOVERNMENT;
FORMULARIES;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INSURANCE, PHARMACEUTICAL SERVICES;
INTERNATIONALITY;
PRESCRIPTIONS, DRUG;
|
|
EID: 16544384964
PISSN: 01565788
EISSN: None
Source Type: Journal
DOI: 10.1071/AH040194 Document Type: Article |
|
Times cited : (39)
|
|
References (0)
|
